TetraLogic Pharmaceuticals Corporation

TLOGOTCHealthcare● Active

$0.00

+$0.00(+0.00%)

Market Cap$979

P/E Ratio—

52W High$0.001

52W Low$0.00004

Avg Volume178

Open$0.00

Beta4.06

Overview

TetraLogic Pharmaceuticals Corporation (TLOG) Insider Trading

Form 4 buy vs sell counts, ratio, and sentiment — switch this quarter or last 12 months; chart and transactions below.

SEC EDGAR · FMP · TLOG · as of Jun 9, 2026

Activity summary

Buy transactions

P-Purchase only

Sell transactions

12 Months

Buy/Sell ratio

0.00

Buy/Sell (by trades)

Overall sentiment

NEUTRAL

↑ Buy 0%Active transactions only · RSU vesting excluded100% Sell ↓

TetraLogic Pharmaceuticals Corporation insiders have shown mixed buying and selling activity over the past 12 Months.

▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · Buy = P-Purchase only · Sell = S-Sale only

As of Jun 9, 2026

Recent insider transactions

TLOG executive sell shares · TLOG board member insider trading · TLOG insider trading SEC filing

Showing 55 most recent · Common Stock · Form 4 only

Scroll horizontally to see all columns

Date	Insider	Type	Shares	Price	Value	After trans.	Filing
Feb 8, 2016	Clarus Lifesciences II, L.P. 10 percent owner	Sale	103,123	$0.19	$20K	2,445,030	Form 4
Feb 9, 2016	Clarus Lifesciences II, L.P. 10 percent owner	Sale	230,507	$0.16	$37K	2,214,523	Form 4
Feb 3, 2016	Clarus Lifesciences II, L.P. 10 percent owner	Sale	82,583	$0.15	$12K	3,881,060	Form 4
Feb 4, 2016	Clarus Lifesciences II, L.P. 10 percent owner	Sale	500,026	$0.14	$70K	3,381,034	Form 4
Feb 5, 2016	Clarus Lifesciences II, L.P. 10 percent owner	Sale	832,881	$0.20	$167K	2,548,153	Form 4
Jan 29, 2016	Clarus Lifesciences II, L.P. 10 percent owner	Sale	52,826	$0.26	$14K	4,279,949	Form 4
Feb 1, 2016	Clarus Lifesciences II, L.P. 10 percent owner	Sale	140,000	$0.20	$28K	4,139,949	Form 4
Feb 2, 2016	Clarus Lifesciences II, L.P. 10 percent owner	Sale	176,306	$0.17	$30K	3,963,643	Form 4
Jan 26, 2016	Clarus Lifesciences II, L.P. 10 percent owner	Sale	69,425	$0.30	$21K	4,575,280	Form 4
Jan 27, 2016	Clarus Lifesciences II, L.P. 10 percent owner	Sale	209,984	$0.27	$57K	4,365,296	Form 4
Jan 28, 2016	Clarus Lifesciences II, L.P. 10 percent owner	Sale	32,521	$0.26	$8K	4,332,775	Form 4
Jul 10, 2015	Pecora Andrew L Director	Purchase	9,200	$2.79	$26K	184,830	Form 4
Jul 10, 2015	Pecora Andrew L Director	Purchase	800	$2.75	$2K	175,630	Form 4
Jul 10, 2015	Pecora Andrew L Director	Purchase	7,608	$2.75	$21K	174,830	Form 4
Jul 10, 2015	Pecora Andrew L Director	Purchase	6,900	$2.74	$19K	167,222	Form 4
Jul 10, 2015	Pecora Andrew L Director	Purchase	10,000	$2.74	$27K	160,322	Form 4
Jul 10, 2015	Pecora Andrew L Director	Purchase	2,100	$2.69	$6K	150,322	Form 4
Jul 10, 2015	Pecora Andrew L Director	Purchase	908	$2.66	$2K	148,222	Form 4
Jul 10, 2015	Pecora Andrew L Director	Purchase	1,092	$2.65	$3K	147,314	Form 4
Jul 10, 2015	Pecora Andrew L Director	Purchase	92	$2.57	$236	146,222	Form 4
Jul 10, 2015	Pecora Andrew L Director	Purchase	1,300	$2.54	$3K	146,130	Form 4
Jul 10, 2015	Pecora Andrew L Director	Purchase	10,000	$2.44	$24K	144,830	Form 4
Jul 9, 2015	Pecora Andrew L Director	Purchase	10,000	$2.41	$24K	134,830	Form 4
Jul 9, 2015	Pecora Andrew L Director	Purchase	40,000	$2.40	$96K	124,830	Form 4
Mar 27, 2015	Meyers Pete A. CFO & Treasurer	Purchase	5,000	$4.35	$22K	153,891	Form 4

Clarus Lifesciences II, L.P.

10 percent owner

Sale

Date

Feb 8

103,123

Price

$0.19

Value

$20K

View Form 4 on SEC.gov

Clarus Lifesciences II, L.P.

10 percent owner

Sale

Date

Feb 9

230,507

Price

$0.16

Value

$37K

View Form 4 on SEC.gov

Clarus Lifesciences II, L.P.

10 percent owner

Sale

Date

Feb 3

82,583

Price

$0.15

Value

$12K

View Form 4 on SEC.gov

Clarus Lifesciences II, L.P.

10 percent owner

Sale

Date

Feb 4

500,026

Price

$0.14

Value

$70K

View Form 4 on SEC.gov

Clarus Lifesciences II, L.P.

10 percent owner

Sale

Date

Feb 5

832,881

Price

$0.20

Value

$167K

View Form 4 on SEC.gov

Clarus Lifesciences II, L.P.

10 percent owner

Sale

Date

Jan 29

52,826

Price

$0.26

Value

$14K

View Form 4 on SEC.gov

Clarus Lifesciences II, L.P.

10 percent owner

Sale

Date

Feb 1

140,000

Price

$0.20

Value

$28K

View Form 4 on SEC.gov

Clarus Lifesciences II, L.P.

10 percent owner

Sale

Date

Feb 2

176,306

Price

$0.17

Value

$30K

View Form 4 on SEC.gov

Clarus Lifesciences II, L.P.

10 percent owner

Sale

Date

Jan 26

69,425

Price

$0.30

Value

$21K

View Form 4 on SEC.gov

Clarus Lifesciences II, L.P.

10 percent owner

Sale

Date

Jan 27

209,984

Price

$0.27

Value

$57K

View Form 4 on SEC.gov

Clarus Lifesciences II, L.P.

10 percent owner

Sale

Date

Jan 28

32,521

Price

$0.26

Value

$8K

View Form 4 on SEC.gov

Pecora Andrew L

Director

Purchase

Date

Jul 10

9,200

Price

$2.79

Value

$26K

View Form 4 on SEC.gov

Pecora Andrew L

Director

Purchase

Date

Jul 10

800

Price

$2.75

Value

$2K

View Form 4 on SEC.gov

Pecora Andrew L

Director

Purchase

Date

Jul 10

7,608

Price

$2.75

Value

$21K

View Form 4 on SEC.gov

Pecora Andrew L

Director

Purchase

Date

Jul 10

6,900

Price

$2.74

Value

$19K

View Form 4 on SEC.gov

Pecora Andrew L

Director

Purchase

Date

Jul 10

10,000

Price

$2.74

Value

$27K

View Form 4 on SEC.gov

Pecora Andrew L

Director

Purchase

Date

Jul 10

2,100

Price

$2.69

Value

$6K

View Form 4 on SEC.gov

Pecora Andrew L

Director

Purchase

Date

Jul 10

908

Price

$2.66

Value

$2K

View Form 4 on SEC.gov

Pecora Andrew L

Director

Purchase

Date

Jul 10

1,092

Price

$2.65

Value

$3K

View Form 4 on SEC.gov

Pecora Andrew L

Director

Purchase

Date

Jul 10

Price

$2.57

Value

$236

View Form 4 on SEC.gov

Pecora Andrew L

Director

Purchase

Date

Jul 10

1,300

Price

$2.54

Value

$3K

View Form 4 on SEC.gov

Pecora Andrew L

Director

Purchase

Date

Jul 10

10,000

Price

$2.44

Value

$24K

View Form 4 on SEC.gov

Pecora Andrew L

Director

Purchase

Date

Jul 9

10,000

Price

$2.41

Value

$24K

View Form 4 on SEC.gov

Pecora Andrew L

Director

Purchase

Date

Jul 9

40,000

Price

$2.40

Value

$96K

View Form 4 on SEC.gov

Meyers Pete A.

CFO & Treasurer

Purchase

Date

Mar 27

5,000

Price

$4.35

Value

$22K

View Form 4 on SEC.gov

⚡ = value ≥ $1M · Award/Option price shows — · formType=4 · securityName=Common Stock · url → sec.gov/Archives/edgar

1 / 3

▸ Source: SEC EDGAR · Form 4 filings · ⚡ = value ≥ $1M · Award/Option price shows —

About TLOG insider trading

TLOG insider trades

TetraLogic Pharmaceuticals Corporation (TLOG) insider trading data is sourced from SEC Form 4 filings submitted by corporate insiders, including TLOG. Over the past 12 months, 0 insiders have filed transactions with the SEC. TLOG insiders have been mixed buying and selling, which may reflect pre-scheduled Rule 10b5-1 plan executions.

For TetraLogic Pharmaceuticals Corporation's institutional ownership breakdown and insider ownership percentage, see the Ownership tab → Ownership tab →

Buy/Sell signal logic

acquisitionOrDisposition field:

A = Acquisition (buy) · D = Disposition (sell)

RSU vesting (M-Exempt) excluded from sentiment

Form 4SEC filing required within 2 business days of any insider transaction

10b5-1Pre-scheduled trading plan that allows insiders to sell on autopilot

Open MktDirect purchase or sale on the open market (excludes awards, options)

Ownership SEC filings Financial statements Price history Forecast & ratings Earnings

Frequently asked questions

TLOG insider trading · 5 questions

The insiders of TetraLogic Pharmaceuticals Corporation (TLOG) include executives and directors such as TLOG, among others. Over the past 12 months, 0 insiders have filed Form 4 transactions with the SEC. Insider transactions are required to be reported within 2 business days of the trade date.

TLOG board member insider tradingwho are TLOG insidersTLOG insider rosterTetraLogic Pharmaceuticals Corporation executives insider activity

▸ Source: FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · acquisitionOrDisposition A=Buy, D=Sell · RSU vesting (M-Exempt) excluded from sentiment bar · As of Jun 9, 2026